Ipca Laboratories Limited
Key Metrics
P/E Ratio
46.15x
Below 15 = value stock, 15-25 = fairly valued, above 30 = growth premium
Price-to-Book (P/B)
5.10x
Below 1.0 = potentially undervalued, 1-3 = typical, banking sector often 1-2x
Earnings Per Share (EPS)
₹35.89
Higher is better — compare within the same industry for meaningful benchmarks
Debt-to-Equity Ratio
0.14x
Below 0.5 = conservative, 0.5-1.0 = moderate, above 2.0 = high leverage
Beta
0.07
1.0 = moves with market, below 0.8 = defensive, above 1.2 = aggressive
52-Week Range Position
98.50%
0% = at 52-week low, 50% = midpoint, 100% = at 52-week high
Dividend Yield
0.24%
2-4% is typical, above 5% is high yield (verify sustainability), 0% = no dividend
Current Market Price
₹1,656.2
Use this to filter by price range — e.g., penny stocks below ₹50, blue chips above ₹1000
Market Capitalisation
₹4201849.2L Cr
Large-cap > ₹20,000 Cr, Mid-cap ₹5,000-20,000 Cr, Small-cap < ₹5,000 Cr
Fifty Two Week High
1662.2
Fifty Two Week Low
1251.6
Run strategies against Ipca Laboratories Limited
Pick a strategy below or run all stock strategies at once.